Related Experiment Video
Updated: Apr 28, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand
Nunzio Denora1, Nicola Margiotta2, Valentino Laquintana1
1Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "A. Moro" , via Orabona 4, 70125 Bari, Italy.
Abstract:
The 18-kDa translocator protein (TSPO) is overexpressed in many types of cancers and is also abundant in activated microglial cells occurring in inflammatory neurodegenerative diseases. Thus, TSPO has become an extremely attractive subcellular target not only for imaging disease states overexpressing this protein, but also for a selective mitochondrial drug delivery. In this work we report the synthesis, the characterization, and the in vitro evaluation of a new TSPO-selective ligand, 2-(8-(2-(bis(pyridin-2-yl)methyl)amino)acetamido)-2-(4-chlorophenyl)H-imidazo[1,2-a]pyridin-3-yl)-N,N-dipropylacetamide (CB256), which fulfils the requirements for a bifunctional chelate approach. The goal was to provide a new TSPO ligand that could be used further to prepare coordination complexes of a metallo drug to be used in diagnosis and therapy. However, the ligand itself proved to be a potent tumor cell growth inhibitor and DNA double-strand breaker.
Insights
A novel 18-kDa translocator protein (TSPO) ligand, CB256, was synthesized and evaluated. This potent molecule inhibits tumor cell growth and causes DNA double-strand breaks, showing dual potential in cancer therapy.
Area of Science:
- Medicinal Chemistry
- Molecular Imaging
- Oncology
Background:
- The 18-kDa translocator protein (TSPO) is overexpressed in cancers and neurodegenerative diseases.
- TSPO is a promising target for disease imaging and targeted drug delivery.
Purpose of the Study:
- To synthesize and characterize a new TSPO-selective ligand, CB256.
- To evaluate CB256 for its potential in diagnostic and therapeutic applications.
Main Methods:
- Synthesis and characterization of the novel ligand CB256.
- In vitro evaluation of CB256's biological activity.
- Assessment of CB256 as a potential bifunctional chelate.
Main Results:
- CB256 demonstrated high selectivity for TSPO.
- The ligand itself exhibited potent tumor cell growth inhibition.
- CB256 was found to be a DNA double-strand breaker.
Conclusions:
- CB256 is a promising TSPO-selective ligand with dual potential.
- CB256 can serve as a basis for developing new diagnostic and therapeutic agents.
- The ligand's intrinsic activity offers direct therapeutic applications in oncology.
Related Concept Videos
EDTA: Chemistry and Properties
Complexometric Titration: Ligands
Complexation Equilibria: The Chelate Effect
Extraction: Advanced Methods

